Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information.
 
DeviceACCESS HYBRITECH P2PSA ON THE ACCESS IMMUNOASSAY SYSTEMS
Generic NameP2psa
ApplicantBeckman Coulter, Inc.
1000 Lake Hazeltine Dr.
Chaska, MN 55318
PMA NumberP090026
Supplement NumberS017
Date Received01/23/2017
Decision Date02/21/2017
Product Code OYA 
Advisory Committee Immunology
Supplement Type30-Day Notice
Supplement Reason Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review Granted? No
Combination ProductNo
Predetermined Change Control Plan AuthorizedNo
Approval Order Statement  
Manufacturing process change to the Working Strength Particle Batch Size process, which is used in the paramagnetic particle (PMP) for use in the Access Hybritech p2PSA Reagent.
-
-